Two Cases of Psoriasis Following Growth Hormone Therapy.
- Author:
Young Soo HEO
1
;
Se Yeong JEONG
;
Jae Eun CHOI
;
Soo Hong SEO
;
Hyo Hyun AHN
;
Young Chul KYE
Author Information
1. Department of Dermatology, College of Medicine, Korea University, Seoul, Korea. yckye@korea.ac.kr
- Publication Type:Case Report
- Keywords:
Growth hormone;
Insulin-like growth factor;
Psoriasis
- MeSH:
Child;
DNA, Recombinant;
Edema;
Growth Hormone;
Humans;
Pseudotumor Cerebri;
Psoriasis;
Skin;
Slipped Capital Femoral Epiphyses
- From:Korean Journal of Dermatology
2009;47(6):714-717
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Growth hormone (GH) has been available for more than 4 decades for the treatment of GH deficiency. But mass production of recombinant DNA growth hormone has made GH therapy widely available for children with no GH deficiency. The use of GH therapy in children has resulted in adverse effects ranging from minor disturbances such as edema and injection site reactions to more significant, but rare events such as benign intracranial hypertension and slipped capital femoral epiphysis. Yet there has been no report in the dermatological field on skin adverse effects associated with GH therapy. We report here on 2 cases of psoriasis following GH therapy in children.
